Table of Contents
The global Agentic AI in Scientific Discovery & Research Market is projected to experience substantial growth, reaching USD 11,191 million by 2034, up from USD 152.1 million in 2024, with a remarkable CAGR of 53.7%. North America leads the market, holding 45.7% of the global share in 2024, generating USD 69.5 million in revenue.
The software segment dominates, capturing 82.4% of the market share. Cloud-based solutions also represent a significant portion, with 59.1% of the market share in 2024. The Healthcare and Pharmaceuticals sector is the largest contributor, accounting for 41.2% of the market share.
How Tariffs are Impacting the Economy
Tariffs on imported goods and services directly affect the economy by raising production costs for businesses that rely on international suppliers. For industries like agentic AI, tariffs on essential hardware components and software tools drive up costs for research and technology development. This can lead to higher pricing for AI-powered solutions, which might reduce demand from cost-sensitive customers.
Additionally, tariffs disrupt global supply chains, making it more difficult for companies to obtain necessary resources in a timely and cost-effective manner. These disruptions can delay research and development efforts, particularly in fields like healthcare and pharmaceuticals, where AI-driven discoveries are crucial.
The uncertainty created by tariffs also affects long-term investment planning, as businesses are unsure about future costs and the availability of key components. In turn, this can slow down the adoption of AI technologies in scientific discovery, potentially hindering advancements in areas such as drug development and medical research.
➤ Discover how our research uncovers business opportunities @ https://market.us/report/agentic-ai-in-scientific-discovery-research-market/free-sample/
Impact on Global Businesses
Global businesses face rising costs due to tariffs, especially in industries like AI-driven scientific discovery and research. The increased cost of essential components such as computing hardware, AI chips, and data infrastructure drives up the overall cost of deploying AI solutions. These higher costs are often passed on to consumers, resulting in more expensive software solutions and reduced demand in price-sensitive sectors.
Furthermore, tariffs disrupt global supply chains, forcing companies to seek new suppliers or move production to countries with more favorable tariffs. In industries like healthcare and pharmaceuticals, where AI plays a critical role in speeding up drug discovery and medical research, these disruptions can delay breakthroughs and innovation.
Additionally, supply chain shifts can lead to delays in the development and deployment of AI-powered research tools, creating a ripple effect across multiple industries, including healthcare, biotechnology, and environmental science.
Strategies for Businesses
To mitigate the impact of rising tariffs, businesses in the agentic AI sector should explore alternatives to sourcing expensive hardware and software components. By diversifying supply chains and establishing partnerships with local or regional suppliers, companies can reduce their reliance on international imports.
Investing in cloud-based platforms, which offer scalable, cost-effective solutions, can also help mitigate the cost increases associated with tariffs on physical infrastructure. Businesses can also focus on optimizing their software to reduce the need for expensive hardware upgrades, thus lowering operational costs.
Additionally, companies can explore nearshoring or reshoring manufacturing to regions with favorable trade policies, reducing the impact of tariffs on their bottom line. By adopting flexible pricing models, leveraging new technologies, and adjusting their supply chain strategies, businesses can better navigate the challenges presented by tariffs while continuing to innovate and grow in the AI-driven research sector.
➤ Explore more strategies get full access now @ https://market.us/purchase-report/?report_id=140242
Key Takeaways
- The Agentic AI in Scientific Discovery & Research Market is expected to grow at a CAGR of 53.7%, reaching USD 11,191 million by 2034.
- North America holds 45.7% of the global market share, with USD 69.5 million in revenue in 2024.
- The software segment leads the market, capturing 82.4% of the share.
- The cloud-based deployment model commands 59.1% of the market share.
- The Healthcare and Pharmaceuticals sector is the largest contributor, holding 41.2% of the market share.
- Tariffs are raising production costs and disrupting global supply chains, particularly in hardware and software components.
Analyst Viewpoint (Present & Future Positive View)
The Agentic AI in Scientific Discovery & Research Market is witnessing robust growth, with increasing demand for AI-driven solutions in sectors like healthcare, pharmaceuticals, and biotechnology. Despite the challenges posed by rising tariffs, businesses that focus on leveraging cloud-based platforms and optimizing their supply chains will remain competitive.
As the demand for AI technologies in scientific research grows, companies that innovate and invest in cost-effective solutions will continue to thrive. The market’s future remains highly positive, with substantial opportunities for growth as industries continue to embrace AI for breakthroughs in medical and scientific research.
Regional Analysis
North America remains the leading region in the Agentic AI in Scientific Discovery & Research Market, capturing 45.7% of the global market share in 2024, with USD 69.5 million in revenue. The U.S. market, valued at USD 63.94 million in 2024, is projected to experience a CAGR of 48.2%.
The demand for AI-powered solutions in healthcare, pharmaceuticals, and biotech is driving growth in North America, with ongoing investment in AI-driven research tools. Europe and Asia-Pacific are also seeing significant growth, with increasing adoption of AI technologies in drug discovery, medical research, and other scientific fields.
➤ Discover More Trending Research
- BNPL Fraud Prevention Market
- AI-driven Meal Planning Apps Market
- Agentic AI for Content Creation Market
- Web3 Social Media Platforms Market
Business Opportunities
The Agentic AI in Scientific Discovery & Research Market offers significant business opportunities, particularly in the healthcare and pharmaceutical sectors, where AI-driven research tools are increasingly used for drug discovery and medical breakthroughs. Companies can capitalize on the growing demand for AI-powered regulatory compliance tools, as well as cloud-based AI platforms that provide scalable, cost-effective solutions.
As digital transformation accelerates, businesses can explore opportunities in emerging markets, where the adoption of AI in scientific research is increasing. Additionally, companies that offer customizable AI solutions for large enterprises will find growth opportunities in these rapidly expanding markets.
Key Segmentation
The Agentic AI in Scientific Discovery & Research Market is segmented by deployment model, software type, application, and region. In terms of deployment models, the cloud-based segment leads with a 59.1% market share in 2024. The software segment captures 82.4% of the market, driven by the growing demand for AI-driven software solutions.
The healthcare and pharmaceuticals sector is the largest application segment, holding 41.2% of the market share. Regionally, North America leads the market with 45.7% of the global share, followed by Europe and Asia-Pacific, where AI adoption in scientific research is rapidly increasing.
Key Player Analysis
Key players in the Agentic AI in Scientific Discovery & Research Market are focusing on developing innovative AI-driven solutions for drug discovery, medical research, and regulatory compliance. These companies are investing in advanced AI technologies, including machine learning and deep learning, to improve the efficiency and accuracy of scientific research.
They are also embracing cloud-based platforms to offer scalable, cost-effective solutions to large enterprises. Strategic partnerships with healthcare and pharmaceutical companies, as well as academic institutions, are enabling key players to expand their market presence and provide tailored AI solutions that address the unique needs of different industries.
Top Key Players in the Market
- OpenAI, LLC
- DeepMind Technologies Limited
- IBM Corporation
- Microsoft Corporation
- NVIDIA Corporation
- Amazon Web Services, Inc.
- Anthropic, Inc.
- Scale AI, Inc.
- Cohere, Inc.
- DataRobot, Inc.
- Other Major Players
Recent Developments
Recent developments in the Agentic AI in Scientific Discovery & Research Market include the launch of new AI-powered research tools that enhance drug discovery and accelerate medical research processes. Companies are also focusing on expanding their cloud-based AI solutions to provide more scalable and flexible services to large enterprises in the healthcare and pharmaceutical sectors.
Conclusion
The Agentic AI in Scientific Discovery & Research Market is poised for strong growth, driven by increasing demand for AI-driven solutions in drug discovery, medical research, and regulatory compliance. North America remains the dominant region, but emerging markets are also witnessing rapid growth. Companies that leverage cloud-based AI technologies and optimize their supply chains will continue to thrive in this expanding market.
Discuss your needs with our analyst
Please share your requirements with more details so our analyst can check if they can solve your problem(s)
